Pages that link to "Q33852396"
Jump to navigation
Jump to search
The following pages link to Targeting protein-protein interactions for therapeutic intervention: a challenge for the future. (Q33852396):
Displaying 50 items.
- Multiprotein complex between the GPI-anchored CyRPA with PfRH5 and PfRipr is crucial for Plasmodium falciparum erythrocyte invasion (Q27230042) (← links)
- Elucidation of New Binding Interactions with the Human Tsg101 Protein Using Modified HIV-1 Gag-p6 Derived Peptide Ligands (Q27666254) (← links)
- Enzyme Inhibition by Allosteric Capture of an Inactive Conformation (Q27670647) (← links)
- Hot-spot analysis to dissect the functional protein-protein interface of a tRNA-modifying enzyme (Q27690810) (← links)
- Structure-Based Identification of Novel Ligands Targeting Multiple Sites within a Chemokine-G-Protein-Coupled-Receptor Interface (Q27704531) (← links)
- Motif mediated protein-protein interactions as drug targets (Q28079554) (← links)
- Evidence of conformational selection driving the formation of ligand binding sites in protein-protein interfaces (Q28543479) (← links)
- Selectivity by small-molecule inhibitors of protein interactions can be driven by protein surface fluctuations (Q28543593) (← links)
- Structure-based inhibition of protein-protein interactions. (Q30367145) (← links)
- PIPINO: A Software Package to Facilitate the Identification of Protein-Protein Interactions from Affinity Purification Mass Spectrometry Data (Q31056803) (← links)
- The role of HTS in drug discovery at the University of Michigan. (Q31147980) (← links)
- The Design and Application of Target-Focused Compound Libraries (Q33882226) (← links)
- Anatomy of β-strands at protein-protein interfaces (Q34061140) (← links)
- Diversity-oriented synthesis: producing chemical tools for dissecting biology (Q34227440) (← links)
- Diversity in genetic in vivo methods for protein-protein interaction studies: from the yeast two-hybrid system to the mammalian split-luciferase system (Q34280863) (← links)
- Overcoming Chemical, Biological, and Computational Challenges in the Development of Inhibitors Targeting Protein-Protein Interactions (Q34481459) (← links)
- Exploring key orientations at protein-protein interfaces with small molecule probes (Q34524107) (← links)
- Druggable protein interaction sites are more predisposed to surface pocket formation than the rest of the protein surface (Q34625325) (← links)
- Synthesis of privileged scaffolds by using diversity-oriented synthesis. (Q34628172) (← links)
- Development of small molecules to target the IgE:FcεRI protein-protein interaction in allergies (Q34898939) (← links)
- Balancing novelty with confined chemical space in modern drug discovery (Q35071339) (← links)
- Identification of Small-Molecule Frequent Hitters from AlphaScreen High-Throughput Screens (Q35076509) (← links)
- Structure-based design of small-molecule protein-protein interaction modulators: the story so far. (Q35103944) (← links)
- Resolving hot spots in the C-terminal dimerization domain that determine the stability of the molecular chaperone Hsp90 (Q35156305) (← links)
- Focused chemical libraries--design and enrichment: an example of protein-protein interaction chemical space (Q35158672) (← links)
- Thermodynamics-Based Drug Design: Strategies for Inhibiting Protein–Protein Interactions (Q35190341) (← links)
- Protein-protein interaction modulator drug discovery: past efforts and future opportunities using a rich source of low- and high-throughput screening assays (Q35397776) (← links)
- Novel and emerging targeted-based cancer therapy agents and methods (Q35558057) (← links)
- Medicinal Chemistry for 2020 (Q35593223) (← links)
- Targeting protein-protein interactions in hematologic malignancies: still a challenge or a great opportunity for future therapies? (Q35687836) (← links)
- DARC 2.0: Improved Docking and Virtual Screening at Protein Interaction Sites (Q35693426) (← links)
- State-of-the-art strategies for targeting protein-protein interactions by small-molecule inhibitors (Q35738960) (← links)
- Probing Protein Surfaces: QSAR Analysis with Helix Mimetics. (Q35874377) (← links)
- Functional advantages of dynamic protein disorder (Q36101573) (← links)
- Effects on polo-like kinase 1 polo-box domain binding affinities of peptides incurred by structural variation at the phosphoamino acid position. (Q36293407) (← links)
- Unexpected involvement of staple leads to redesign of selective bicyclic peptide inhibitor of Grb7. (Q36964946) (← links)
- Protein kinase C, an elusive therapeutic target? (Q37141320) (← links)
- A New G-Quadruplex with Hairpin Loop Immediately Upstream of the Human BCL2 P1 Promoter Modulates Transcription (Q37249260) (← links)
- Elucidating the druggable interface of protein-protein interactions using fragment docking and coevolutionary analysis. (Q37515109) (← links)
- Targeting the hypoxia-inducible factor (HIF) pathway in cancer. (Q37587446) (← links)
- Patented inhibitors of p53-Mdm2 interaction (2006 - 2008). (Q37680961) (← links)
- Using Peptides to Study Protein–Protein Interactions (Q37855887) (← links)
- Druggability Assessment of Protein–Protein Interfaces (Q37958066) (← links)
- In silico fragment-based drug design (Q38029118) (← links)
- Pharmaceutical implications of helix length control in helix-mediated protein-protein interactions. (Q38164842) (← links)
- Review cyclic peptides on a merry-go-round; towards drug design (Q38476515) (← links)
- Modulation of nociceptive ion channels and receptors via protein-protein interactions: implications for pain relief (Q38514549) (← links)
- 3-substituted indazoles as configurationally locked 4EGI-1 mimetics and inhibitors of the eIF4E/eIF4G interaction (Q39031191) (← links)
- Thioether-Derived Macrocycle for Peptide Secondary Structure Fixation (Q39159976) (← links)
- A homogeneous HTRF assay for the identification of inhibitors of the TWEAK-Fn14 protein interaction. (Q39340509) (← links)